Cargando…

A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer

Lung cancer is the leading cause of cancer deaths worldwide, and this makes it an attractive disease to review and possibly improve therapeutic treatment options. Surgery, radiation, chemotherapy, targeted treatments, and immunotherapy separate or in combination are commonly used to treat lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chih-Yang, Ju, Da-Tong, Chang, Chih-Fen, Muralidhar Reddy, P., Velmurugan, Bharath Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	EDP Sciences 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682982/ https://www.ncbi.nlm.nih.gov/pubmed/29130448 http://dx.doi.org/10.1051/bmdcn/2017070423

Ejemplares similares

Cardiovascular Disease and Possible Ways in Which Lycopene Acts as an Efficient Cardio-Protectant against Different Cardiovascular Risk Factors
por: Hsieh, Ming-Ju, et al.
Publicado: (2022)

16-Hydroxycleroda-3,13-dien-15,16-olide and N-Methyl-Actinodaphine Potentiate Tamoxifen-Induced Cell Death in Breast Cancer
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2018)

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
por: Russo, Francesca, et al.
Publicado: (2008)

An innovation percutaneous needle knife use for trigger finger: A retrospective cohort study
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2023)

Febrile neutropenia in chemotherapy treated small-cell lung cancer patients
por: Kukec, Renata Rezonja, et al.
Publicado: (2015)

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
por: Selvamuthukumar, Subramanian, et al.
Publicado: (2012)

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
por: Ulahannan, Susanna V, et al.
Publicado: (2011)

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
por: Liang, Yi-Hsin, et al.
Publicado: (2016)

No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
por: Li, Feng, et al.
Publicado: (2021)

Quantitative Proteomic Analysis of Human Lung Tumor Xenografts Treated with the Ectopic ATP Synthase Inhibitor Citreoviridin
por: Wu, Yi-Hsuan, et al.
Publicado: (2013)

The Role of Monoclonal Antibody in Combination with First-Line Chemotherapy in Asian Patients with Advanced Non-Small Cell Lung Cancer
por: Cho, Byoung Chul, et al.
Publicado: (2010)

Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy
por: Choi, Hyun Chang, et al.
Publicado: (2015)

Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases
por: Huang, Chi-Ping, et al.
Publicado: (2021)

Current Evidence of Natural Agents in Oral and Periodontal Health
por: Isola, Gaetano
Publicado: (2020)

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients
por: Liu, Chia-Hsin, et al.
Publicado: (2015)

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis
por: Chiu, Tzu-Hsuan, et al.
Publicado: (2022)

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
por: Bergot, Emmanuel, et al.
Publicado: (2013)

Tuberculosis chemotherapy: current drug delivery approaches
por: du Toit, Lisa Claire, et al.
Publicado: (2006)

Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
por: Xu, J. L., et al.
Publicado: (2015)

A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer
por: Zhao, Qingda, et al.
Publicado: (2020)

A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer
por: Johnson, P W M, et al.
Publicado: (2001)

Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
por: Vendetti, Frank P., et al.
Publicado: (2014)

Peripheral Immune Cell Gene Expression Changes in Advanced Non-Small Cell Lung Cancer Patients Treated with First Line Combination Chemotherapy
por: Chen, Yung-Che, et al.
Publicado: (2013)

Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent
por: Segura-Carretero, Antonio, et al.
Publicado: (2018)

The Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems
por: Dai, Chongshan, et al.
Publicado: (2022)

Natural Products as Anticancer Agents: Current Status and Future Perspectives
por: Naeem, Abid, et al.
Publicado: (2022)

Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023)

Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
por: Li, Lianbo
Publicado: (2022)

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
por: Omersa, Daniel, et al.
Publicado: (2016)

Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy
por: Kanaji, Nobuhiro, et al.
Publicado: (2020)

Safety and Efficacy of Mild Moxibustion on Cancer-Related Fatigue in Non-Small-Cell Lung Cancer Patients Undergoing Chemotherapy
por: Xu, Xiaomin, et al.
Publicado: (2022)

Current Research and Development of Chemotherapeutic Agents for Melanoma
por: Hsan, Kyaw Minn, et al.
Publicado: (2010)

A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)
por: Zhang, Jiashuai, et al.
Publicado: (2023)

Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989)

Agents to treat BRAF-mutant lung cancer
por: Alvarez, Jean G Bustamante, et al.
Publicado: (2019)

Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells
por: Lee, An-Fu, et al.
Publicado: (2017)

Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer
por: Gandhi, Sona, et al.
Publicado: (2023)

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab
por: Ko, How-Wen, et al.
Publicado: (2022)

Photosensitive Supramolecular Micelle-Mediated Cellular Uptake of Anticancer Drugs Enhances the Efficiency of Chemotherapy
por: Alemayehu, Yihalem Abebe, et al.
Publicado: (2020)

Histology transformation-mediated pathological atypism in small-cell lung cancer within the presence of chemotherapy: A case report
por: Ju, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66rjptstjj96jdrl27gs2gr95g